Avenue Therapeutics, Inc, a specialized pharmaceutical company dedicated to advancing therapies for neurologic diseases, has successfully enrolled all participants in the Phase 1b/2a clinical trial of AJ201

Windtree Therapeutics, Inc, a biotechnology company specializing in advanced interventions for critical cardiovascular disorders, has announced novel preclinical data on its lead product candidate, istaroxime,

ANGLE plc, a prominent player in liquid biopsy technology focused on circulating tumor cell diagnostics for research, drug development, and clinical oncology, has recently entered into a noteworthy agreement with Eisai Inc

Cyclo Therapeutics, Inc.and Applied Molecular Transport Inc. have successfully concluded their merger, an all-stock transaction that unites the two biotechnology companies.

Scilex Holding Company is a company dedicated to acquiring, developing, and commercializing non-opioid pain management products for both acute and chronic pain. Today, the company announced the submission

Senhwa Biosciences, Inc., a company focused on drug development for oncology, rare diseases, and infectious diseases, has received approval from the Taiwan Food and Drug Administration for its Phase II

Virax Biolabs Group Limited has recently entered into a strategic collaboration with the University of Manchester and the Northern Care Alliance Foundation Trust. The partnership

Ocelot Bio, a clinical-stage biopharmaceutical company focused on developing innovative therapeutics for complications of end-stage liver disease (ESLD), has received Orphan Drug Designation from the U.S

Bio-Techne Corporation has recently submitted a Drug Master File to the U.S. Food and Drug Administration for its ExCellerate™ GMP iPSC Expansion Medium,

IGC Pharma, Inc., a clinical-stage pharmaceutical company, has received a Granting Office Action from the Divisional Direction of Patents, Mexico, for its Alzheimer's disease treatment